A deficient immune response to viral infections predicts asthma persistence in children Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016
Identification of viral species in asthma patients with and without aspirin hypersensitivity Source: Annual Congress 2013 –Viral infections Year: 2013
NLRP3 inflammasome-mediated, IL-1β-dependent inflammatory responses drive steroid-resistant asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016
Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Crucial timing of a viral component exposure to exacerbate allergen-induced asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013
The effect of influenza virus infection on airway inflammation in a murine model of asthma Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
D-tryptophan influences allergic airway inflammation and Th2 immune responses Source: International Congress 2015 – Asthma mechanisms and management Year: 2015
Dysregulation of type 2 innate lymphoid cells and Th2 cells impairs pollutant-induced allergic airway responses Source: International Congress 2016 – Immune responses in the lung Year: 2016
LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015
Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013
PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013
Investigation the role of pentraxin-3 in the innate immune system in patients with COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015
Chemokines, innate and adaptive immunity, and respiratory disease Source: Eur Respir J 2002; 19: 350-355 Year: 2002
Comparing the effects of oxidative stress on mitochondrial function and antiviral responses in primary bronchial epithelial cells of asthmatics and non-asthmatics Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Airway inflammation in patients with different levels of asthma control Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013
LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016
The role of IL-17 producing NK cells and other innate immune cells in poly(I:C) triggered exacerbation of experimental asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016
LATE-BREAKING ABSTRACT: The role of IL-17A in the pathogenesis of early infection with RSV increasing susceptibility to asthma Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015
Asthma patients hospitalized with influenza lack mucosal and systemic type 2 inflammation Source: International Congress 2016 – Molecular immunology of the lung Year: 2016